风湿病研究中支持将工作时生产力损失测量作为一项结局指标的OMERACT筛选证据
OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.
作者信息
Beaton Dorcas E, Dyer Sarah, Boonen Annelies, Verstappen Suzanne M M, Escorpizo Reuben, Lacaille Diane V, Bosworth Ailsa, Gignac Monique A M, Leong Amye, Purcaru Oana, Leggett Sarah, Hofstetter Cathy, Peterson Ingemar F, Tang Kenneth, Fautrel Bruno, Bombardier Claire, Tugwell Peter S
机构信息
From the Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester, UK; Bone and Joint Decade, the Global Alliance for Musculoskeletal Health, Santa Barbara, California, USA; Consumer Advisory Council, Canadian Arthritis Network, Canada; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Rehabilitation and Movement Science, The University of Vermont, Burlington, Vermont, USA; Department of Rheumatology, Pierre et Marie Curie University (UPMC - Paris 6), APHP Pitié-Salpétriêre Hospital, Paris, France; Department of Rheumatology, Skåne University Hospital, Malmo; Department of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden; Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht, the Netherlands; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia, Canada; Health Economics, GMAP, Immunology, UCB BioPharma SPRL, Brussells, Belgium; Institute for Work and Health; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Toronto General Research Institute at the University Health Network, Toronto, Ontario, Canada.D. Lacaille holds the Mary Pack Chair in Arthritis Research from The Arthritis Society of Canada and the University of British Columbia. C. Bombardier holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care and a Pfizer Chair in Rheumatology, University of Toronto, Faculty of Medicine's Rheumatology Division.D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Institute of Health Policy, Management and Evaluation, Rehabilitation Sciences Institute,
出版信息
J Rheumatol. 2016 Jan;43(1):214-22. doi: 10.3899/jrheum.141077. Epub 2015 Sep 1.
OBJECTIVE
Indicators of work role functioning (being at work, and being productive while at work) are important outcomes for persons with arthritis. As the worker productivity working group at OMERACT (Outcome Measures in Rheumatology), we sought to provide an evidence base for consensus on standardized instruments to measure worker productivity [both absenteeism and at-work productivity (presenteeism) as well as critical contextual factors].
METHODS
Literature reviews and primary studies were done and reported to the OMERACT 12 (2014) meeting to build the OMERACT Filter 2.0 evidence for worker productivity outcome measurement instruments. Contextual factor domains that could have an effect on scores on worker productivity instruments were identified by nominal group techniques, and strength of influence was further assessed by literature review.
RESULTS
At OMERACT 9 (2008), we identified 6 candidate measures of absenteeism, which received 94% endorsement at the plenary vote. At OMERACT 11 (2012) we received over the required minimum vote of 70% for endorsement of 2 at-work productivity loss measures. During OMERACT 12 (2014), out of 4 measures of at-work productivity loss, 3 (1 global; 2 multiitem) received support as having passed the OMERACT Filter with over 70% of the plenary vote. In addition, 3 contextual factor domains received a 95% vote to explore their validity as core contextual factors: nature of work, work accommodation, and workplace support.
CONCLUSION
Our current recommendations for at-work productivity loss measures are: WALS (Workplace Activity Limitations Scale), WLQ PDmod (Work Limitations Questionnaire with modified physical demands scale), WAI (Work Ability Index), WPS (Arthritis-specific Work Productivity Survey), and WPAI (Work Productivity and Activity Impairment Questionnaire). Our future research focus will shift to confirming core contextual factors to consider in the measurement of worker productivity.
目的
工作角色功能指标（出勤以及工作时的生产力）是关节炎患者的重要结局。作为风湿病结局评估（OMERACT）工作组中的工作生产力小组，我们力求为就测量工作生产力的标准化工具（包括旷工率、工作时生产力损失率以及关键背景因素）达成共识提供证据基础。
方法
开展文献综述和原始研究，并在OMERACT 12（2014年）会议上进行报告，以构建用于测量工作生产力结局指标的OMERACT Filter 2.0证据。通过名义群体技术确定可能影响工作生产力工具得分的背景因素领域，并通过文献综述进一步评估影响强度。
结果
在OMERACT 9（2008年）会议上，我们确定了6项旷工率候选测量指标，这些指标在全会投票中获得了94%的认可。在OMERACT 11（2012年）会议上，我们获得了超过所需的70%最低投票数，以认可2项工作时生产力损失测量指标。在OMERACT 12（2014年）会议期间，在4项工作时生产力损失测量指标中，3项（1项综合指标；2项多项目指标）获得支持，因其在全会投票中超过70%的票数通过了OMERACT Filter。此外，3个背景因素领域获得了95%的票数，以探讨其作为核心背景因素的有效性：工作性质、工作适应性和工作场所支持。
结论
我们目前对于工作时生产力损失测量指标的建议是：工作场所活动受限量表（WALS）、修改后的体力需求工作限制问卷（WLQ PDmod）、工作能力指数（WAI）、关节炎特异性工作生产力调查（WPS）以及工作生产力和活动障碍问卷（WPAI）。我们未来的研究重点将转向确认在测量工作生产力时需考虑的核心背景因素。
Zotero 插件